Race modifies survival benefit of guideline‐based treatment: Implications for reducing disparities in muscle invasive bladder cancer

Race modifies survival benefit of guideline‐based treatment: Implications for reducing disparities in muscle invasive bladder cancer

Abstract Background Black individuals with muscle‐invasive bladder cancer (MIBC) experienced 21% lower odds of guideline‐based treatment (GBT) and differences in treatment explain 35% of observed Black‐White differences in survival. Yet little is known of how interactions between race/ethnicity and...

Full description

Bibliographic Details
Main Authors: Samuel L. Washington III, Steven E. Gregorich, Maxwell V. Meng, Anne M. Suskind, Sima P. Porten
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Cancer Medicine
Subjects:
African continental ancestry group
cohort studies
social determinants of health
United States
urinary bladder neoplasms
Online Access:https://doi.org/10.1002/cam4.3429

Internet

https://doi.org/10.1002/cam4.3429

Similar Items